{"transactions":[{"id":730206,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSU","published_at":"2026-06-22T23:50:57.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":5248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units were received as a compensatory award for services rendered or to be rendered."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest in equal quarterly installments over a one-year period following the date of grant, subject to the Reporting Person's continued service. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest in equal quarterly installments over a one-year period following the date of grant, subject to the Reporting Person's continued service. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."}],"balance_after":5248,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5248},"source":{"system":"sec-edgar","filing":"0001493152-26-029657","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000149315226029657/ownership.xml","form_type":"4"}},{"id":739414,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:22:42.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.74,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-26-073587","document":"tm2617745-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000110465926073587/tm2617745-6_4seq1.xml","form_type":"4"}},{"id":739413,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:22:42.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 10, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":64000,"source":{"system":"sec-edgar","filing":"0001104659-26-073587","document":"tm2617745-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000110465926073587/tm2617745-6_4seq1.xml","form_type":"4"}},{"id":771504,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-19T11:00:10.000Z","date":"2026-05-18","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":31.07,"value":31070.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001493152-26-024342","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000149315226024342/ownership.xml","form_type":"4"}},{"id":802607,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T20:31:08.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":24367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":127514,"source":{"system":"sec-edgar","filing":"0000905148-26-001786","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001786/form4.xml","form_type":"4"}},{"id":950607,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-05T21:22:44.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":23643,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for 2026. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock the day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $1.99 per share, the average of the high and low price of the common stock, the day prior to the grant date."}],"balance_after":103147,"source":{"system":"sec-edgar","filing":"0000905148-26-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000031/form4.xml","form_type":"4"}},{"id":1102490,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSU","published_at":"2025-06-24T22:51:39.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":7339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units were received as a compensatory award for services rendered or to be rendered."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of Restricted Stock Units vests in full on the one-year anniversary following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of Restricted Stock Units vests in full on the one-year anniversary following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."}],"balance_after":7339,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7339},"source":{"system":"sec-edgar","filing":"0001641172-25-016322","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000164117225016322/ownership.xml","form_type":"4"}},{"id":1111214,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:21:40.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-25-059379","document":"tm2517945-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000110465925059379/tm2517945-1_4seq1.xml","form_type":"4"}},{"id":1111213,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:21:40.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001104659-25-059379","document":"tm2517945-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000110465925059379/tm2517945-1_4seq1.xml","form_type":"4"}},{"id":1160925,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-02T21:06:36.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79592,"derivative":{"exercise_price":0.95,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":79592},"source":{"system":"sec-edgar","filing":"0000905148-25-001428","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001428/form4.xml","form_type":"4"}},{"id":1160924,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-02T21:06:36.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79504,"source":{"system":"sec-edgar","filing":"0000905148-25-001428","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001428/form4.xml","form_type":"4"}},{"id":1381860,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-10-24T21:59:15.000Z","date":"2024-10-22","kind":"grant","planned":false,"acquired":true,"shares":172874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in a series of three equal annual installments over the three-year period measured from the grant date of October 22, 2024, subject to the Reporting Person's continuing service."}],"balance_after":172874,"derivative":{"exercise_price":1.33,"expiration_date":"2034-10-21","underlying":"Common Stock","underlying_shares":172874},"source":{"system":"sec-edgar","filing":"0000905148-24-002828","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514824002828/form4.xml","form_type":"4"}},{"id":1447967,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T22:38:40.000Z","date":"2024-07-24","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":36000,"derivative":{"exercise_price":7.91,"expiration_date":"2034-07-23","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001104659-24-083096","document":"tm2420266-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000110465924083096/tm2420266-1_4seq1.xml","form_type":"4"}},{"id":1447966,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-26T22:38:40.000Z","date":"2024-07-24","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 24, 2024, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":36000,"source":{"system":"sec-edgar","filing":"0001104659-24-083096","document":"tm2420266-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000110465924083096/tm2420266-1_4seq1.xml","form_type":"4"}},{"id":1477004,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSU","published_at":"2024-06-17T22:00:09.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":8347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units were received as a compensatory award for services rendered or to be rendered."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."}],"balance_after":8347,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8347},"source":{"system":"sec-edgar","filing":"0001493152-24-024193","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000149315224024193/ownership.xml","form_type":"4"}},{"id":1666369,"issuer":{"id":4740,"kind":"organization","name":"HARROW, INC."},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSU","published_at":"2024-01-30T21:10:43.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":3119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units were received as a compensatory award for services rendered or to be rendered."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of Restricted Stock Units vests in full on June 21, 2024. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of Restricted Stock Units vests in full on June 21, 2024. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service."}],"balance_after":3119,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3119},"source":{"system":"sec-edgar","filing":"0001493152-24-004313","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000149315224004313/ownership.xml","form_type":"4"}},{"id":1830196,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-13T14:00:12.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23186,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":9.94,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":23186},"source":{"system":"sec-edgar","filing":"0001104659-23-080688","document":"tm2321002-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080688/tm2321002-9_4seq1.xml","form_type":"4"}},{"id":1830195,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-13T14:00:12.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":6.82,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001104659-23-080688","document":"tm2321002-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080688/tm2321002-9_4seq1.xml","form_type":"4"}},{"id":1830194,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-13T14:00:12.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":4.14,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-23-080688","document":"tm2321002-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080688/tm2321002-9_4seq1.xml","form_type":"4"}},{"id":1830193,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-13T14:00:12.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-23-080688","document":"tm2321002-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080688/tm2321002-9_4seq1.xml","form_type":"4"}},{"id":1830192,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-13T14:00:12.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":1.45,"expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001104659-23-080688","document":"tm2321002-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080688/tm2321002-9_4seq1.xml","form_type":"4"}},{"id":1830191,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-07-13T14:00:12.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each IVERIC restricted stock unit (\"RSU\") represented the contingent right to receive one share of Common Stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-23-080688","document":"tm2321002-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080688/tm2321002-9_4seq1.xml","form_type":"4"}},{"id":1830190,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-13T14:00:12.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22088,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 11, 2023, pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated April 28, 2023, by and among IVERIC bio, Inc. (\"IVERIC\"), Astellas US Holding, Inc., Berry Merger Sub, Inc. (\"Merger Sub\") and, solely as provided by Section 8.10(b) of the Merger Agreement, Astellas Pharma Inc. (\"Astellas\"), Merger Sub merged with and into IVERIC, with IVERIC surviving the merger and becoming an indirect wholly owned subsidiary of Astellas (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), each share of IVERIC common stock (\"Common Stock\") reported in this Form 4 was automatically cancelled and was converted into the right to receive $40.00 in cash, without interest and less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-080688","document":"tm2321002-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080688/tm2321002-9_4seq1.xml","form_type":"4"}},{"id":1830835,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-12T21:18:40.000Z","date":"2023-07-10","kind":"grant","planned":false,"acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest over three years, vesting 1/3 on each yearly anniversary of the date of grant."}],"balance_after":72000,"derivative":{"exercise_price":5.04,"expiration_date":"2033-07-09","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001104659-23-080407","document":"tm2321019-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000110465923080407/tm2321019-3_4seq1.xml","form_type":"4"}},{"id":1830834,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-12T21:18:40.000Z","date":"2023-07-10","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 10, 2023, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest over three years, vesting 1/3 on each yearly anniversary of the date of grant."}],"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001104659-23-080407","document":"tm2321019-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326192/000110465923080407/tm2321019-3_4seq1.xml","form_type":"4"}},{"id":1884393,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-19T17:57:31.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2023 Stock Incentive Plan, the award of restricted stock units will vest in full on the earlier of one business day prior to the Registrant's 2024 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the award of restricted stock units will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2023 Stock Incentive Plan). For purposes of this report on Form 4, a change in control event includes the closing of the transaction contemplated by the Agreement and Plan of Merger, dated April 28, 2023, between the Registrant, Astellas US Holding, Inc., Berry Merger Sub, Inc. and solely as provided by Section 8.10(b) of such agreement, Astellas Pharma Inc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2023 Stock Incentive Plan, the award of restricted stock units will vest in full on the earlier of one business day prior to the Registrant's 2024 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the award of restricted stock units will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2023 Stock Incentive Plan). For purposes of this report on Form 4, a change in control event includes the closing of the transaction contemplated by the Agreement and Plan of Merger, dated April 28, 2023, between the Registrant, Astellas US Holding, Inc., Berry Merger Sub, Inc. and solely as provided by Section 8.10(b) of such agreement, Astellas Pharma Inc."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001410939-23-000091","document":"wk-form4_1684533440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093923000091/wk-form4_1684533440.xml","form_type":"4"}},{"id":1893369,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-15T16:48:06.000Z","date":"2023-05-11","kind":"exercise","planned":false,"acquired":false,"shares":14588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with the Registrant's Non-Employee Director Compensation Policy, the Reporting Person was granted 14,588 of the Registrant's restricted stock units on May 12, 2022. Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units vested in full one business day prior to the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In accordance with the Registrant's Non-Employee Director Compensation Policy, the Reporting Person was granted 14,588 of the Registrant's restricted stock units on May 12, 2022. Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units vested in full one business day prior to the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14588},"source":{"system":"sec-edgar","filing":"0001410939-23-000074","document":"wk-form4_1684183672.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093923000074/wk-form4_1684183672.xml","form_type":"4"}},{"id":1893368,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T16:48:06.000Z","date":"2023-05-11","kind":"exercise","planned":false,"acquired":true,"shares":14588,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":22088,"source":{"system":"sec-edgar","filing":"0001410939-23-000074","document":"wk-form4_1684183672.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093923000074/wk-form4_1684183672.xml","form_type":"4"}},{"id":2271841,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-13T18:09:14.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":23186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In accordance with the Registrant's Non-Employee Director Compensation Policy, the Reporting Person was granted a stock option to purchase 23,186 shares of the Registrant's common stock. Subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest monthly with respect to 1/12 of the shares underlying such stock option award until the earlier of the business day immediately prior to the Registrant's 2023 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the stock option award will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2013 Stock Incentive Plan)."}],"balance_after":23186,"derivative":{"exercise_price":9.94,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":23186},"source":{"system":"sec-edgar","filing":"0001410939-22-000071","document":"wf-form4_165247964037531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000071/wf-form4_165247964037531.xml","form_type":"4"}},{"id":2271840,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-13T18:09:14.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":14588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In accordance with the Registrant's Non-Employee Director Compensation Policy, the Reporting Person was granted 14,588 restricted stock units. Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest in full on the earlier of one business day prior to the Registrant's 2023 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the award of restricted stock units will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2013 Stock Incentive Plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In accordance with the Registrant's Non-Employee Director Compensation Policy, the Reporting Person was granted 14,588 restricted stock units. Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest in full on the earlier of one business day prior to the Registrant's 2023 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the award of restricted stock units will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2013 Stock Incentive Plan)."}],"balance_after":14588,"derivative":{"underlying":"Common Stock","underlying_shares":14588},"source":{"system":"sec-edgar","filing":"0001410939-22-000071","document":"wf-form4_165247964037531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000071/wf-form4_165247964037531.xml","form_type":"4"}},{"id":2271839,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-13T18:09:14.000Z","date":"2022-05-11","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 19, 2021, the Reporting Person was granted 7,500 restricted stock units, which vest in full upon on the earlier of one business day prior to the Registrant's 2022 annual meeting of stockholders or the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 19, 2021, the Reporting Person was granted 7,500 restricted stock units, which vest in full upon on the earlier of one business day prior to the Registrant's 2022 annual meeting of stockholders or the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001410939-22-000071","document":"wf-form4_165247964037531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000071/wf-form4_165247964037531.xml","form_type":"4"}},{"id":2271838,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T18:09:14.000Z","date":"2022-05-11","kind":"exercise","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001410939-22-000071","document":"wf-form4_165247964037531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000071/wf-form4_165247964037531.xml","form_type":"4"}},{"id":2702916,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-20T19:52:23.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest in full on the earlier of one business day prior to the Registrant's 2022 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the award of restricted stock units will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2013 Stock Incentive Plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest in full on the earlier of one business day prior to the Registrant's 2022 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the award of restricted stock units will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2013 Stock Incentive Plan)."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-21-070098","document":"tm2117174-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921070098/tm2117174-2_4seq1.xml","form_type":"4"}},{"id":2702915,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T19:52:23.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest monthly with respect to 1/12 of the shares underlying such stock option award until the earlier of the business day immediately prior to the Registrant's 2022 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the stock option award will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2013 Stock Incentive Plan)."}],"balance_after":15500,"derivative":{"exercise_price":6.82,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001104659-21-070098","document":"tm2117174-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921070098/tm2117174-2_4seq1.xml","form_type":"4"}},{"id":3113258,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T14:01:39.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the option will vest and become exercisable in 12 consecutive, equal installments on each consecutive monthly anniversary of the date of grant, until fully vested and exercisable on the first anniversary of the date of grant. Any unvested shares subject to the option will be accelerated in full one business day prior to the Registrant's 2021 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the option will vest and become exercisable in 12 consecutive, equal installments on each consecutive monthly anniversary of the date of grant, until fully vested and exercisable on the first anniversary of the date of grant. Any unvested shares subject to the option will be accelerated in full one business day prior to the Registrant's 2021 annual meeting of stockholders."}],"balance_after":16000,"derivative":{"exercise_price":4.14,"underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-20-072340","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920072340/a4.xml","form_type":"4"}},{"id":3523670,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-16T17:12:59.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to Reporting Person providing continued services to the Issuer and other terms and conditions under the Issuer's 2013 Stock Incentive Plan, the option will vest and become exercisable in 12 consecutive, equal installments on each consecutive monthly anniversary of the date of grant, until fully vested and exercisable on the first anniversary of the date of grant. Any unvested shares subject to the option will be accelerated in full one business day prior to the Issuer's 2020 annual meeting of stockholders."}],"balance_after":16000,"derivative":{"exercise_price":1.39,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-19-030030","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465919030030/a4.xml","form_type":"4"}},{"id":3531085,"issuer":{"id":146919,"kind":"organization","name":"AKORN INC","symbol":"AKRXQ"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-05-13T21:27:58.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":58775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Options vest in four equal installments on May 9, 2020, May 9, 2021, May 9, 2022, and May 9, 2023."}],"balance_after":58775,"derivative":{"exercise_price":4.47,"expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":58775},"source":{"system":"sec-edgar","filing":"0001144204-19-025734","document":"tv521508_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/3116/000114420419025734/tv521508_4.xml","form_type":"4"}},{"id":3531084,"issuer":{"id":146919,"kind":"organization","name":"AKORN INC","symbol":"AKRXQ"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T21:27:58.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":30760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities acquired are Restricted Stock Units (RSUs) scheduled to vest in four equal installments on May 9, 2020, May 9, 2021, May 9, 2022 and May 9, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the reported transaction, the amount of shares beneficially owned includes 46,610 unvested RSUs and 31,088 shares owned outright."}],"balance_after":77698,"source":{"system":"sec-edgar","filing":"0001144204-19-025734","document":"tv521508_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/3116/000114420419025734/tv521508_4.xml","form_type":"4"}},{"id":3730570,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-14T17:11:09.000Z","date":"2018-12-12","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting commencement date (\"Vesting Commencement Date\") of the option is December 12, 2018. The option vests with respect to one-thirty sixth (1/36th) of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":32000,"derivative":{"exercise_price":1.45,"expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001104659-18-073128","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465918073128/a4.xml","form_type":"4"}},{"id":3959086,"issuer":{"id":146919,"kind":"organization","name":"AKORN INC","symbol":"AKRXQ"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-23T19:07:50.000Z","date":"2018-04-19","kind":"grant","acquired":true,"shares":14189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities acquired are Restricted Stock Units (RSUs) scheduled to vest in four equal installments on April 19, 2019, April 19, 2020, April 19, 2021 and April 19, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the reported transaction, the amount of shares beneficially owned includes 24,607 unvested RSUs and 22,331 shares owned outright."}],"balance_after":46938,"source":{"system":"sec-edgar","filing":"0001171843-18-002959","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/3116/000117184318002959/formfour.xml","form_type":"4"}},{"id":4332909,"issuer":{"id":146919,"kind":"organization","name":"AKORN INC","symbol":"AKRXQ"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-05T17:00:52.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":8088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities acquired are Restricted Stock Units (RSUs) scheduled to vest in four equal installments on May 4, 2018, May 4, 2019, May 4, 2020 and May 4, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the reported transaction, the amount of shares beneficially owned includes 11,583 unvested RSUs and 21,166 shares owned outright."}],"balance_after":32749,"source":{"system":"sec-edgar","filing":"0001171843-17-002736","document":"f4_050417graves.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/3116/000117184317002736/f4_050417graves.xml","form_type":"4"}},{"id":4459092,"issuer":{"id":146919,"kind":"organization","name":"AKORN INC","symbol":"AKRXQ"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-02-10T16:30:14.000Z","date":"2017-02-08","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":12.87,"exercise_date":"2012-03-02","expiration_date":"2017-03-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001171843-17-000815","document":"f4_graves020917.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/3116/000117184317000815/f4_graves020917.xml","form_type":"4"}},{"id":4459091,"issuer":{"id":146919,"kind":"organization","name":"AKORN INC","symbol":"AKRXQ"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-10T16:30:14.000Z","date":"2017-02-08","kind":"exercise","acquired":true,"shares":20000,"price":12.87,"value":257400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Following the reported transaction, the amount of shares beneficially owned includes 3,495 unvested shares subject to restricted stock awards and 21,166 shares owned outright."}],"balance_after":24661,"source":{"system":"sec-edgar","filing":"0001171843-17-000815","document":"f4_graves020917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/3116/000117184317000815/f4_graves020917.xml","form_type":"4"}}]}